Acarbose treatment increases serum total adiponectin levels in patients with type 2 diabetes.

@article{Ochiai2008AcarboseTI,
  title={Acarbose treatment increases serum total adiponectin levels in patients with type 2 diabetes.},
  author={Hiromi Ochiai and Hikari Ooka and Chiho Shida and Toshio Ishikawa and D Inoue and Ryo Okazaki},
  journal={Endocrine journal},
  year={2008},
  volume={55 3},
  pages={549-56}
}
Adiponectin is an anti-diabetic and anti-atherogenic adipokine that serves as a major determinant of insulin sensitivity. Thiazolidine derivatives increase circulating adiponectin, particularly the high molecular weight isoform, which has been shown to well correlate with amelioration of insulin resistance by thiazolidines in diabetic patients. alpha-glucosidase inhibitors are another class of anti-diabetic agents that specifically reduce postprandial blood glucose elevations, but its effect on… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus

Diabetes, metabolic syndrome and obesity : targets and therapy • 2015

Current status of therapy in nonalcoholic Fatty liver disease.

Therapeutic advances in gastroenterology • 2009
View 1 Excerpt

The clinical implications of blood adiponectin in cardiometabolic disorders.

Journal of the Formosan Medical Association = Taiwan yi zhi • 2009

Similar Papers

Loading similar papers…